Two-fold regional variation in initiation of anti-osteoporosis medication after hip fracture in the UK

Dettagli Bibliografici
Autori principali:	Shah, A, Prieto-Alhambra, D, Hawley, S, Delmestri, A, Lippett, J, Cooper, C, Judge, A, Javaid, M
Natura:	Conference item
Pubblicazione:	Springer Verlag 2016

Two-fold regional variation in initiation of anti-osteoporosis medication after hip fracture in the UK
di: Shah, A, et al.
Pubblicazione: (2016)

Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study
di: Shah, A, et al.
Pubblicazione: (2016)

Anti-osteoporosis medication prescriptions and incidence of secondary fracture amongst hip fracture patients in England and Wales: an age stratified interrupted time series analysis
di: Hawley, S, et al.
Pubblicazione: (2018)

Anti-osteoporosis medication prescriptions and incidence of subsequent fracture among primary hip fracture patients in England and Wales: an interrupted time-series analysis
di: Hawley, S, et al.
Pubblicazione: (2016)

Clinical effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: population-based longitudinal study
di: Hawley, S, et al.
Pubblicazione: (2016)

Descriptive epidemiology of hip and knee replacement in rheumatoid arthritis: an analysis of UK electronic medical records
di: Hawley, S, et al.
Pubblicazione: (2019)

Cost-effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: a population based study
di: Leal, J, et al.
Pubblicazione: (2016)

Models of care for the delivery of secondary fracture prevention after hip fracture: a health service cost, clinical outcomes and cost-effectiveness study within a region of England
di: Judge, A, et al.
Pubblicazione: (2016)

Descriptive epidemiology of hip and knee replacement among rheumatoid arthritis patients in England and Wales: variation by age, sex, geography and socioeconomic status
di: Hawley, S, et al.
Pubblicazione: (2017)

Comparative fracture risk amongst users of different anti-osteoporosis drugs available in the UK in the NHS: A propensity-matched cohort study using data from the Clinical Practice Research Datalink
di: Khalid, S, et al.
Pubblicazione: (2016)

Total hip and knee replacement among incident osteoarthritis and rheumatoid arthritis patients within the UK Clinical Practice Research Datalink (CPRD) compared to hospital episode statistics (HES): a validation study
di: Hawley, S, et al.
Pubblicazione: (2016)

Comparative fracture risk amongst users of different anti-osteoporosis therapies: meta-analysis of propensity-matched cohort studies using data from the Clinical Practice Research Datalink (UK) and SIDIAP (Spain).
di: Khalid, S, et al.
Pubblicazione: (2017)

Models of care for the delivery of secondary fracture prevention after hip fracture: a health service cost, clinical outcomes and cost-effectiveness study within a region of England
di: Andrew Judge, et al.
Pubblicazione: (2016-09-01)

Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK
di: Martín-Merino, E, et al.
Pubblicazione: (2017)

Comparative anti-fracture effectiveness of different anti-osteoporosis medications amongst male drug users in real world clinical practice: a population-based cohort study
di: Zwart, M, et al.
Pubblicazione: (2016)

Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on “real-world” data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database
di: Khalid, S, et al.
Pubblicazione: (2018)

Comparative risk of venous thromboembolism among users of different anti-osteoporosis drugs in the UK National Health Service and in Catalonia, Spain: A propensity-matched cohort study
di: Khalid, S, et al.
Pubblicazione: (2017)

Geographical variation in surgical care and mortality following hip fracture in England: a cohort study using the National Hip Fracture Database (NHFD)
di: Shah, A, et al.
Pubblicazione: (2021)

Comparative risk of venous thromboembolism amongst users of different anti-osteoporosis drugs in the uk: a propensity-matched cohort study using data from the clinical practice research datalink
di: Khalid, S, et al.
Pubblicazione: (2016)

Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial.
di: Prieto-Alhambra, D, et al.
Pubblicazione: (2014)

Bariatric surgery increases the rate of major fracture: self-controlled case series study in UK Clinical Practice Research Datalink
di: Robinson, DE, et al.
Pubblicazione: (2021)

Risk of venous thromboembolism amongst users of different anti-osteoporosis drugs: a multinational population-based cohort study
di: Martin-Merino, E, et al.
Pubblicazione: (2016)

Higher prevalence of non-skeletal comorbidity related to X-linked hypophosphataemia: A UK parallel cohort study using CPRD
di: Hawley, S, et al.
Pubblicazione: (2020)

Major osteoporotic fracture risk following bariatric surgery: a self-controlled case series including 5,492 people from the UK CPRD and linked HES databases
di: Robinson, DE, et al.
Pubblicazione: (2019)

UK TEMPORAL TRENDS FOR TIME FROM DIAGNOSIS OF HIP/KNEE OSTEOARTHRITIS TO JOINT REPLACEMENT
di: Culliford, D, et al.
Pubblicazione: (2014)

Future Projections Of Total Hip And Knee Arthroplasty In The Uk: Results From The Uk Clinical Practice Research Datalink.
di: Culliford, D, et al.
Pubblicazione: (2015)

Incidence of total hip and knee replacement in UK patients with ankylosing spondylitis
di: Hawley, S, et al.
Pubblicazione: (2018)

Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database
di: Khalid, S, et al.
Pubblicazione: (2022)

Effect of intra-articular corticosteroid injections for osteoarthritis on the subsequent use of pain medications: a UK CPRD cohort study
di: Hawley, S, et al.
Pubblicazione: (2025)

Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a mutli-national study including data from Denmark, Spain, and the UK
di: Khalid, S, et al.
Pubblicazione: (2018)

The Impact of Biologic Therapy Introduction on Hip and Knee Replacement Among Rheumatoid Arthritis Patients: An Interrupted Time Series Analysis Using the Clinical Practice Research Datalink
di: Hawley, S, et al.
Pubblicazione: (2016)

Comparative risk of acute myocardial infarction among users of different anti-osteoporosis drugs in Catalonia, Spain: A propensity matched cohort study using data from the SIDIAP database
di: Khalid, S, et al.
Pubblicazione: (2017)

Describing variation in the delivery of secondary fracture prevention after hip fracture: an overview of 11 hospitals within one regional area in England.
di: Drew, S, et al.
Pubblicazione: (2014)

CHANGES IN HIP FRACTURE RATE BEFORE AND AFTER TOTAL KNEE REPLACEMENT DUE TO OSTEOARTHRITIS: A POPULATION-BASED COHORT STUDY
di: Prieto-Alhambra, D, et al.
Pubblicazione: (2010)

Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study.
di: Prieto-Alhambra, D, et al.
Pubblicazione: (2011)

Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use.
di: Prieto-Alhambra, D, et al.
Pubblicazione: (2011)

Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: an interrupted time-series analysis
di: Hawley, S, et al.
Pubblicazione: (2017)

Imminent fracture risk amongst new users of oral bisphosphonates in actual practice settings: A multi-national European cohort study from Denmark, Spain, and the UK
di: Khalid, S, et al.
Pubblicazione: (2019)

[Degenerative osteoarthritis, osteoporosis and fractures: controversies and evidences].
di: Pagès-Castellà, A, et al.
Pubblicazione: (2013)

Two-fold regional variation in initiation of anti-osteoporosis medication after hip fracture in the UK

Documenti analoghi

Documenti analoghi